Immunohistochemical analysis of estrogen receptor (ER), progesterone receptor (PR) and HER2 receptor enables a crude association with the hormone-sensing lineage (ER+, PR+) and basal-like (ER-, PR-, HER2-) subtypes of breast cancer. Here, ERBB2 is linked to breast carcinoma.